Comparison of EQ-5D and SF-6D utilities in Pompe disease

被引:12
|
作者
Kanters, T. A. [1 ,2 ]
Redekop, W. K. [1 ]
Kruijshaar, M. E. [2 ,3 ]
van der Ploeg, A. T. [2 ,3 ]
Rutten-van Molken, M. P. M. H. [1 ]
Hakkaart, L. [1 ]
机构
[1] Erasmus Univ, Inst Med Technol Assessment, Dept Hlth Policy & Management, NL-3000 DR Rotterdam, Netherlands
[2] Erasmus MC Univ, Med Ctr, Ctr Lysosomal & Metab Dis, NL-3015 GJ Rotterdam, Netherlands
[3] Erasmus MC Univ, Med Ctr Rotterdam, Dept Pediat, Div Metab Dis & Genet, NL-3015 GJ Rotterdam, Netherlands
关键词
Preference-based measure of health; EQ-5D; SF-6D; Orphan disease; Pompe disease; HEALTH; ADULTS; INSTRUMENTS; PROGRESSION; VALIDITY; EUROQOL; IMPACT;
D O I
10.1007/s11136-014-0833-2
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Comparative studies between Euroqol-5D (EQ-5D) and ShortForm 6D (SF-6D) utilities have been performed for a number of diseases, but not yet for orphan diseases. Pompe disease is an orphan disease with a prevalence of < 5/10,000, characterized by impaired ambulatory and pulmonary functioning. We compared the psychometric properties of EQ-5D and SF-6D in patients with this disease and assessed their convergent validity, discriminative ability and sensitivity to change. EQ-5D utilities and SF-6D utilities were computed using the UK value set. Dimensions and utilities of the two instruments were compared by correlation coefficients and descriptive statistics. We assessed whether EQ-5D and SF-6D were able to discriminate between different levels of severity and examined sensitivity to change for patients with multiple observations. Correlations between theoretically related dimensions of the EQ-5D and SF-6D were highly significant and were moderate to strong (range rho = 0.409-0.564). Utility values derived from the two instruments were similar (mean EQ-5D = 0.670; mean SF-6D = 0.699) and correlated strongly (rho = 0.591). Discriminative properties were somewhat better for EQ-5D; mean changes and effect sizes were better for SF-6D. Overall, we conclude that both instruments appear to be equally appropriate with respect to assessing utilities in Pompe disease, but neither of them performed excellently. The descriptive system of the SF-6D describes health states for Pompe disease more accurately. EQ-5D showed better discriminative properties. The SF-6D performed better with respect to sensitivity to change.
引用
收藏
页码:837 / 844
页数:8
相关论文
共 50 条
  • [21] Scale Characteristics and Mapping Accuracy of the US EQ-5D, UK EQ-5D, and SF-6D in Patients with Rheumatoid Arthritis
    Wolfe, Frederick
    Michaud, Kaleb
    Wallenstein, Gene
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (08) : 1615 - 1625
  • [22] Comparison between EQ-5D and SF-6D Utility in Rural Residents of Jiangsu Province, China
    Jin, Hui
    Wang, Bei
    Gao, Qian
    Chao, Jianqian
    Wang, Siyuan
    Tian, Lin
    Liu, Pei
    PLOS ONE, 2012, 7 (07):
  • [23] The comparative responsiveness of the EQ-5D and SF-6D to change in patients with inflammatory arthritis
    Harrison, M. J.
    Davies, L. M.
    Bansback, N. J.
    McCoy, M. J.
    Verstappen, S. M. M.
    Watson, K.
    Symmons, D. P. M.
    QUALITY OF LIFE RESEARCH, 2009, 18 (09) : 1195 - 1205
  • [24] The classification systems of the EQ-5D, the HUI II and the SF-6D: what do they have in common?
    Konerding, Uwe
    Moock, Joern
    Kohlmann, Thomas
    QUALITY OF LIFE RESEARCH, 2009, 18 (09) : 1249 - 1261
  • [25] Comparison of the EQ-5D and the SF-6D Utility Measures in 813 Patients with Early Arthritis: Results from the ESPOIR Cohort
    Gaujoux-Viala, Cecile
    Rat, Anne-Christine
    Guillemin, Francis
    Flipo, Rene-Marc
    Fardellone, Patrice
    Bourgeois, Pierre
    Fautrel, Bruno
    JOURNAL OF RHEUMATOLOGY, 2011, 38 (08) : 1576 - 1584
  • [26] Discriminative capacity of the EQ-5D, SF-6D, and SF-12 as measures of health status in population health survey
    Cunillera, Oriol
    Tresserras, Ricard
    Rajmil, Luis
    Vilagut, Gemma
    Brugulat, Pilar
    Herdman, Mike
    Mompart, Anna
    Medina, Antonia
    Pardo, Yolanda
    Alonso, Jordi
    Brazier, John
    Ferrer, Montse
    QUALITY OF LIFE RESEARCH, 2010, 19 (06) : 853 - 864
  • [27] Population Norms for the EQ-5D-5L, PROPr and SF-6D in Hungary
    Nikl, Anna
    Janssen, Mathieu F.
    Jenei, Balazs
    Brodszky, Valentin
    Rencz, Fanni
    PHARMACOECONOMICS, 2024, 42 (05) : 583 - 603
  • [28] Comparing measurement properties of EQ-5D and SF-6D in East and South-East Asian populations: a scoping review
    Zhang, Aixue
    Mao, Zhuxin
    Wang, Zitong
    Wu, Jing
    Luo, Nan
    Wang, Pei
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2023, 23 (05) : 449 - 468
  • [29] A comparison of the measurement properties and estimation of minimal important differences of the EQ-5D and SF-6D utility measures in patients with systemic sclerosis
    Kwakkenbos, L.
    Fransen, J.
    Vonk, M. C.
    Becker, E. S.
    Jeurissen, M.
    van den Hoogen, F. H. J.
    van den Ende, C. H. M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2013, 31 (02) : S50 - S56
  • [30] Estimating the burden of disease in chronic pain with and without neuropathic characteristics: Does the choice between the EQ-5D and SF-6D matter?
    Torrance, Nicola
    Lawson, Kenny D.
    Afolabi, Ebenezer
    Bennett, Michael I.
    Serpell, Michael G.
    Dunn, Kate M.
    Smith, Blair H.
    PAIN, 2014, 155 (10) : 1996 - 2004